Expert review of pharmacoeconomics & outcomes research

Expert review of pharmacoeconomics & outcomes research

Indexed In	ncbi ulakbim MEP: 0.644 Ödeme: 3220 Yılı: 2020 sci soc
Short Name	Expert Rev Pharmacoecon Outcomes Res
Abbreviated Name	expert rev pharmacoecon outcomes res
Publications/Year
ISSN	1744-8379
Aim and Scope
URL
Author Instructions

Top Clicked Bibliographies from Search

2019 Increased burden of disease and role of health economics: Asia-pacific region. Clicks: 285

2019 Estimating the money flow in the economy attributed to rotavirus disease and vaccination in the Netherlands using a Social Accounting Matrix (SAM) framework. Clicks: 276

2019 A case study applying a novel approach to estimate the social impact of a medical innovation - the use of secukinumab for psoriatic arthritis in Germany. Clicks: 254

2020 impact of atherosclerotic cardiovascular disease on healthcare resource utilization and costs in patients with type 2 diabetes mellitus in a real-world setting Clicks: 244

2019 Generic atorvastatin and rosuvastatin in the South Korean market: time of introduction in relation to manufacturer characteristics. Clicks: 222

2020 Barriers and facilitators of exploiting the potential of value-added medicines. Clicks: 212